| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,381 |
11,905 |
$538K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,758 |
7,484 |
$440K |
| 80305 |
|
12,930 |
9,207 |
$96K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
364 |
309 |
$19K |
| 96127 |
|
1,917 |
1,424 |
$9K |
| 99406 |
|
690 |
581 |
$5K |
| 96160 |
|
942 |
709 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
64 |
54 |
$734.58 |
| 99401 |
|
105 |
88 |
$46.77 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
14 |
13 |
$39.14 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
60 |
36 |
$15.45 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
49 |
29 |
$10.45 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$6.63 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
421 |
366 |
$0.00 |
| 1101F |
|
120 |
107 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
601 |
503 |
$0.00 |
| G9583 |
Patients prescribed opiates for longer than six weeks |
4,030 |
2,956 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
427 |
387 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
407 |
316 |
$0.00 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
318 |
262 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
4,392 |
3,031 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,096 |
3,009 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
1,154 |
967 |
$0.00 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
4,033 |
2,962 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
4,039 |
2,963 |
$0.00 |
| G9561 |
Patients prescribed opiates for longer than six weeks |
4,020 |
2,952 |
$0.00 |
| G9577 |
Patients prescribed opiates for longer than six weeks |
4,026 |
2,954 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
4,153 |
2,974 |
$0.00 |
| 3288F |
|
47 |
36 |
$0.00 |